ASHLEY HEUER: Open Payments
NPI 1871030338 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125 in 5 payments from 5 companies in 2025. Trend: 2023 $295 · 2024 $269 · 2025 $125
Food & beverage: $125
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $25 |
| LEO Pharma Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
Products named: DUPIXENT, Rhapsido, ADBRY, TREMFYA.
Industry payments across OR — which companies pay providers there.
